UFLEX Limited (UFLEX)
Transcript of the earnings conference call conducted on November 16, 2026
AI summary
- Q2 FY27 consolidated revenue grew 26% y-y to Rs.48,694 million; normalized EBITDA up 95% y-y to Rs.7,588 million with 15.6% margin (+550 bps); PAT rose 689% y-y to Rs.2,106 million (4.3% margin)
- Overseas operations contributed 56% of incremental revenue and 74% of incremental EBITDA; India contributed 44% and 26% respectively
- Sales volume up 1.5% y-y to 163,532 MT; packaging films volume +3%, packaging business volume -3.9% due to strategic shift to higher-margin products
- Capex Rs.5,689 million in Q2 FY27 for Egypt aseptic plant, Noida recycling unit, Dharwad BOPP line
- FY27 outlook: targeting ~30% revenue and EBITDA growth; H1 achieved ~50% revenue and ~60% EBITDA of full-year targets
- Egypt aseptic plant commissioning expected H2 FY27; ramp to 100% capacity by FY29; WPP bag facility in Mexico at 30-35% utilization, targeting 100% by FY29
- Focus on value-added products to improve margins; overseas margins higher than India; blended margin ~15%, sustainable and expected to improve
- Recycling capacity utilization to improve by FY28 due to government mandates
- Capacity utilization ~80% currently, aiming for 90%+ next year to drive margin expansion
- Aseptic packaging seasonal with Q4 and Q1 strongest; major growth driver and value-added segment
- Leverage reduced to 3.33x EBITDA in Q2 FY27; expected to improve as new capacities commercialize
- Management confident on sustaining growth and profitability over 3-5 year horizon
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 UFLEX — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add UFLEX to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on UFLEX Limited
Important.
The summary above is generated automatically from UFLEX Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.